Palo Alto Investors’s Abiomed Inc ABMD Stock Holding History

Palo Alto Investors’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-490,754	Closed	-$121M	–	32
2022 Q3	$121M	Sell	490,754 -3,643	-0.7%	-$984K	9.53%	4
2022 Q2	$122M	Hold	494,397	–	–	10.67%	3
2022 Q1	$164M	Sell	494,397 -24,636	-5%	-$7.58M	12.66%	2
2021 Q4	$186M	Sell	519,033 -30,787	-6%	-$10.4M	11.91%	2
2021 Q3	$179M	Sell	549,820 -34,113	-6%	-$11.6M	10.8%	1
2021 Q2	$182M	Buy	583,933 +8,700	+2%	+$2.67M	10.04%	3
2021 Q1	$183M	Buy	575,233 +18,600	+3%	+$5.95M	10.45%	3
2020 Q4	$180M	Buy	556,633 +52,600	+10%	+$14.5M	9.46%	5
2020 Q3	$140M	Buy	504,033 +11,700	+2%	+$3.37M	7.67%	4
2020 Q2	$119M	Sell	492,333 -10,412	-2%	-$2.09M	7.14%	5
2020 Q1	$73M	Sell	502,745 -61,423	-11%	-$10.2M	6.11%	7
2019 Q4	$96.2M	Sell	564,168 -90,260	-14%	-$16.7M	5.3%	8
2019 Q3	$116M	Sell	654,428 -51,926	-7%	-$11.2M	7.75%	3
2019 Q2	$184M	Buy	706,354 +7,700	+1%	+$2.04M	8.95%	3
2019 Q1	$200M	Buy	698,654 +9,104	+1%	+$3.03M	8.32%	3
2018 Q4	$224M	Sell	689,550 -19,367	-3%	-$6.73M	11.93%	1
2018 Q3	$319M	Sell	708,917 -181,392	-20%	-$71.5M	12.89%	1
2018 Q2	$364M	Sell	890,309 -456,351	-34%	-$165M	14.55%	1
2018 Q1	$392M	Sell	1,346,660 -238,753	-15%	-$60.5M	16.76%	1
2017 Q4	$297M	Sell	1,585,413 -349,887	-18%	-$65.3M	12.8%	1
2017 Q3	$326M	Sell	1,935,300 -15,984	-0.8%	-$2.42M	13.74%	1
2017 Q2	$280M	Buy	1,951,284 +29,800	+2%	+$4M	13.05%	2
2017 Q1	$241M	Buy	1,921,484 +17,900	+0.9%	+$2.07M	11.37%	3
2016 Q4	$214M	Buy	1,903,584 +19,200	+1%	+$2.22M	12.24%	2
2016 Q3	$242M	Sell	1,884,384 -182,535	-9%	-$21.9M	14.07%	1
2016 Q2	$226M	Sell	2,066,919 -259,040	-11%	-$25.8M	17.06%	1
2016 Q1	$221M	Sell	2,325,959 -563,546	-20%	-$47.6M	17.12%	1
2015 Q4	$261M	Buy	2,889,505 +62,500	+2%	+$5.3M	14.52%	1
2015 Q3	$262M	Buy	2,827,005 +84,700	+3%	+$7.46M	12.61%	3
2015 Q2	$180M	Buy	2,742,305 +268,681	+11%	+$17.9M	8.01%	5
2015 Q1	$177M	Buy	2,473,624 +13,500	+0.5%	+$733K	8.75%	4
2014 Q4	$93.6M	Buy	2,460,124 +30,600	+1%	+$965K	5.5%	6
2014 Q3	$60.3M	Buy	2,429,524 +222,035	+10%	+$5.62M	4.51%	7
2014 Q2	$55.5M	Buy	2,207,489 +5,200	+0.2%	+$121K	4.13%	7
2014 Q1	$57.3M	Sell	2,202,289 -485,058	-18%	-$13.4M	4.74%	7
2013 Q4	$71.9M	Buy	2,687,347 +33,000	+1%	+$815K	6.7%	5
2013 Q3	$50.6M	Buy	2,654,347 +334,949	+14%	+$7.66M	5.3%	7
2013 Q2	$50M	Buy	+2,319,398	New	+$46.6M	5.9%	5

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Palo Alto Investors's ABMD Position: Q4 2022 in Review

Palo Alto Investors sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 490,754 shares — an estimated $121M sold.

Palo Alto Investors first reported a position in ABMD in Q2 2013 and held it in 38 quarters. The position peaked at $392M in Q1 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

Palo Alto Investors reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
Palo Alto Investors sold 490,754 Abiomed Inc shares in Q4 2022, an estimated $121M.
Palo Alto Investors first reported a position in Abiomed Inc in Q2 2013 and held it in 38 quarters.
Palo Alto Investors's Abiomed Inc position peaked at $392M in Q1 2018.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Palo Alto Investors's 13F filing for Q4 2022, filed 14 Feb 2023.